Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Laouafa 2019 Acta Physiol (Oxf)

From Bioblast
Publications in the MiPMap
Laouafa S, Roussel D, Marcouiller F, Soliz J, Gozal D, Bairam A, Joseph V (2019) Roles of oestradiol receptor alpha and beta against hypertension and brain mitochondrial dysfunction under intermittent hypoxia in female rats. Acta Physiol (Oxf) 226:e13255.

» PMID: 30635990

Laouafa S, Roussel D, Marcouiller F, Soliz J, Gozal D, Bairam A, Joseph V (2019) Acta Physiol (Oxf)

Abstract: Chronic intermittent hypoxia (CIH) induces systemic (hypertension) and central (mitochondrial dysfunction underlying cognitive deficits). We hypothesized that agonists of oestradiol receptors (ER) α and β prevent CIH-induced hypertension and brain mitochondrial dysfunction.

Ovariectomized female rats were implanted with osmotic pumps delivering vehicle (Veh), the ERα agonist propylpyraoletriol (PPT - 30μg/kg/day) or the ERβ agonist diarylpropionitril (DPN - 100μg/kg/day). Animals were exposed to CIH (21-10% FIO2 - 10 cycles/hour - 8 hours/day - 7 days) or normoxia. Arterial blood pressure was measured after CIH or normoxia exposures. Mitochondrial respiration and H2O2 production were measured in brain cortex with high-resolution respirometry, as well as activity of complex I and IV of the electron transport chain, citrate synthase, pyruvate and lactate dehydrogenase (PDH and LDH).

PPT but not DPN prevented the rise of arterial pressure induced by CIH. CIH exposures decreased O2 consumption, complex I activity, and increased H2O2 production. CIH had no effect on citrate synthase activity, but decreased PDH activity and increased LDH activity indicating higher anaerobic glycolysis. PPT and DPN treatments prevented all these alterations.

We conclude that in OVX female rats, the ERα agonist prevents from CIH-induced hypertension while both ERα and ERβ agonists prevent the brain mitochondrial dysfunction and metabolic switch induced by CIH. These findings may have implications for menopausal women suffering of sleep apnoea regarding hormonal therapy. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved. Keywords: Hormonal therapy, Hypertension, Metabolic switch, Mitochondrial dysfunction, Selective oestradiol receptor modulators, Sleep apnoea Bioblast editor: Plangger M O2k-Network Lab: CA Quebec Soliz J


Labels: MiParea: Respiration, Pharmacology;toxicology 

Stress:Hypoxia  Organism: Rat  Tissue;cell: Nervous system  Preparation: Permeabilized tissue  Enzyme: Complex I, Complex IV;cytochrome c oxidase, TCA cycle and matrix dehydrogenases 

Coupling state: LEAK, OXPHOS, ET  Pathway: N, S, CIV, NS, ROX  HRR: Oxygraph-2k, O2k-Fluorometer 

2019-01, AmR